This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
RETRACTION: Evaluation of Bevacizumab Biosimilar on Wound Healing Complications in Patients with Colorectal Cancer Undergoing Endoscopic Mucosal Resection: A Systematic Review and Meta‐Analysis in Anorectal Medicine
TL;DR
This retracted study claimed to evaluate a biosimilar drug's effect on wound healing in colorectal cancer patients but was found to have used a compromised peer review process.
Contribution
The paper's findings and conclusions are invalid due to a flawed peer review process.
Findings
The article was retracted due to a compromised peer review process.
The authors did not respond to the retraction notice.
The study's results cannot be trusted or relied upon.
Abstract
RETRACTION: LiY. , MeiZ. , ShiL. , WanY. , ZhouX. , ZengT. , LiuY. , YangJ. Y. , and ShiZ. , “Evaluation of Bevacizumab Biosimilar on Wound Healing Complications in Patients with Colorectal Cancer Undergoing Endoscopic Mucosal Resection: A Systematic Review and Meta‐Analysis in Anorectal Medicine,” International Wound Journal 21, no. 1 (2024): e14638, 10.1111/iwj.14638.38272807 PMC10805537 The above article, published online on 23 January 2024, in Wiley Online Library (http://onlinelibrary.wiley.com/), has been retracted by agreement between the journal Editor in Chief, Professor Keith Harding; and John Wiley & Sons Ltd. Following an investigation by the publisher, all parties have concluded that this article was accepted solely on the basis of a compromised peer review process. The editors have therefore decided to retract the article. The authors did not respond to our…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsColorectal Cancer Surgical Treatments · Inflammatory Bowel Disease · Surgical site infection prevention
RETRACTION:
Y. Li , Z. Mei , L. Shi , Y. Wan , X. Zhou , T. Zeng , Y. Liu , J. Y. Yang , and Z. Shi , “Evaluation of Bevacizumab Biosimilar on Wound Healing Complications in Patients with Colorectal Cancer Undergoing Endoscopic Mucosal Resection: A Systematic Review and Meta‐Analysis in Anorectal Medicine,” International Wound Journal 21, no. 1 (2024): e14638, 10.1111/iwj.14638.38272807 PMC10805537
The above article, published online on 23 January 2024, in Wiley Online Library (http://onlinelibrary.wiley.com/), has been retracted by agreement between the journal Editor in Chief, Professor Keith Harding; and John Wiley & Sons Ltd. Following an investigation by the publisher, all parties have concluded that this article was accepted solely on the basis of a compromised peer review process. The editors have therefore decided to retract the article. The authors did not respond to our notice regarding the retraction.